# MARGENZA

NDC: 74527-022
Generic name: margetuximab-cmkb
Labeler / Manufacturer: MacroGenics, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20210115

FDA application: BLA761150

## Active ingredients

- MARGETUXIMAB: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"74527-022"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=74527-022
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e97a5872-eabf-463b-8f4c-5b5aed9c7bf0